OXFORD, Miss., July 6, 2007 (PRIME NEWSWIRE) -- Modern Technology Corp (Pink Sheets:MODC), a bioscience technology development and acquisition company, announced today Dr. Marc Rose of VitalCare will present the company's AnuCyte Cancer Detection System at the annual meeting of the Cancer Control Society in Los Angeles, California on September 1st through Sept. 3rd, 2007. The presentation of the technology is part of the agreement between the Company and VitalCare as part of our continuing effort to promote and create market awareness of the service.
Anthony Welch, Chairman, said: "As previously stated, we are moving forward with the marketing and development of the AnuCyte Cancer Detection Service and the associated revenues from the sale of the service. We expect to receive a tremendous level of interest from the Society's meeting. We are not aware of any system that can do what AnuCyte does. The power and significance of the system speaks for itself. "
Dr. Marc Rose, Co-Founder of VitalCare, said, "Clearly the technology behind the AnuCyte system is something truly incredible. I anticipate an equally significant response by the Society Members."
About the AnuCyte Cancer Detection System
The AnuCyte Cancer Detection System is an automated machine to detect the presence of cancer in cell samples. The system accurately identifies cancer at any stage in its development and also identifies healthy cancer-free cells in the same test within the same sample. The system is designed based on the chromosomal imbalance theory of cancer. Over the prior ten years the chromosomal imbalance theory of cancer has been proven correct both experimentally and theoretically in numerous, rigorously peer-reviewed publications in the leading journals. The system's accuracy in detecting the presence or absence of cancer is effectively 100%.
About Modern Technology Corp
Modern Technology Corp, a bioscience technology development and acquisition company, builds revenues through a model continuous growth, strategic acquisitions, and commercialization of nascent technology. The Company files reports with the U.S. Securities and Exchange Commission. For the company's filings, visit http://www.sec.gov.
Safe-Harbor Statement
This press release contains statements (such as projections regarding future performance) that are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those projected as a result of certain risks and uncertainties, including but not limited to those detailed from time to time in the Company's filings with the Securities and Exchange Commission.